![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/415 | (2006.01) |
A61P 35/00 | (2018.01) | ||
A61P 19/00 | (2006.01) | ||
A61P 19/00 | (2018.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/415 | (2013.01) | ||
C07D 231/12 | (2006.01) |
(11) | Number of the document | 3541380 |
(13) | Kind of document | T |
(96) | European patent application number | 17870813.7 |
Date of filing the European patent application | 2017-11-16 | |
(97) | Date of publication of the European application | 2019-09-25 |
(45) | Date of publication and mention of the grant of the patent | 2021-12-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2017/051368 |
Date | 2017-11-16 |
(87) | Number | WO 2018/090137 |
Date | 2018-05-24 |
(30) | Number | Date | Country code |
201662423019 P | 2016-11-16 | US |
(72) |
LEMIRE, Isabelle , CA
HARVEY, Michael , CA
GROGAN, Donna Roy , US
DESJARDINS, Clarissa , CA
|
(73) |
Clementia Pharmaceuticals Inc. ,
1000 de la Gauchetière O, suite 1200, Montreal, QC H3B 4W5,
CA
|
(54) | METHODS FOR TREATING MULTIPLE OSTEOCHONDROMA (MO) |
METHODS FOR TREATING MULTIPLE OSTEOCHONDROMA (MO) |